The Relationship Between Body Awareness and Clinical Parameters in Patients With Obstructive Sleep Apnea
| Registry | NCT07743892 |
|---|
| Status | Recruiting |
|---|
| Study type | Observational |
|---|
| Enrollment | 47 (Estimated) |
|---|
| Sponsor | Karabuk University (Other) |
|---|
| Conditions | Obstructive Sleep Apnea (OSAS) |
|---|
| Dates | start 2026-05-21, primary completion 2027-05-21 (estimated), completion 2027-06-30 (estimated), first posted 2026-08-04, last updated 2026-08-04 |
|---|
| Locations | 1 site in Turkey (Türkiye) |
|---|
Related Papers Related Patents Related Grants Related Experts
All trials for Obstructive Sleep Apnea (OSAS)
-Summary
Obstructive Sleep Apnea Syndrome (OSAS) is a chronic disease characterized by intermittent hypoxia and sleep fragmentation resulting from recurrent upper airway obstructions. The physiological and neurocognitive changes caused by the disease can affect how individuals perceive and interpret bodily sensations. Although body awareness plays a significant role in the perception and management of symptoms, its relationship with clinical parameters in individuals with OSAS has not been sufficiently investigated. Therefore, the aim of our study is to examine the relationship between body awareness and respiratory function, disease severity, fatigue, shortness of breath, and sleep quality in OSAS patients.
Expand all sections · Collapse all
+Arms and interventions
| Arm | Type | Interventions | Description |
|---|
| Obstructive Sleep Apnea Syndrome Group | | | Patients diagnosed with Obstructive Sleep Apnea Syndrome |
+Outcome measures
Primary outcomes
- Body awareness [Baseline]: The Body Awareness Questionnaire (BAQ) will be used to assess individuals' body awareness. The scale score ranges from 18 to 26, with higher scores indicating higher awareness.
- Dyspnea [Baseline]: Dyspnea is assessed with the modified Medical Research Council (mMRC) dyspnea scale. As the score increases, shortness of breath increases.
- Disease severity [Baseline]: The evaluation will be based on the Apnea/Hypopnea index measured by polysomnography. An Apnea-Hypopnea Index >5 indicates Obstructive Sleep Apnea Syndrome.
- Fatigue severity [Baseline]: Fatigue will be assessed using the Fatigue Severity Scale. A score of 36 or higher indicates severe fatigue.
- Sleep quality [Baseline]: Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PUKI). The total score ranges from 0 to 21, and a score above 5 indicates poor sleep quality.
- Pulmonary function (Forced vital capacity (FVC) [Baseline]: Pulmonary function will be evaluated using the spirometry, according to American Thoracic Society and European Respiratory Society criteria. Forced vital capacity (FVC) will be measured.
- Pulmonary function (Forced expiratory volume in the first second (FEV1) [Baseline]: Pulmonary function will be evaluated using the spirometry, according to American Thoracic Society and European Respiratory Society criteria. Forced expiratory volume in the first second (FEV1) will be measured.
- Pulmonary function (FEV1 / FVC) [Baseline]: Pulmonary function will be evaluated using the spirometry, according to American Thoracic Society and European Respiratory Society criteria. FEV1 / FVC will be measured.
- Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%)) [Baseline]: Pulmonary function will be evaluated using the spirometry, according to American Thoracic Society and European Respiratory Society criteria. Flow rate 25-75% of forced expiratory volume (FEF 25-75%) will be measured.
- Pulmonary function (Peak flow rate (PEF)) [Baseline]: Pulmonary function will be evaluated using the spirometry, according to American Thoracic Society and European Respiratory Society criteria. Peak flow rate (PEF) will be measured.
+Eligibility
Sex: All, ages: 18 Years to 65 Years, accepts healthy volunteers
Inclusion Criteria:
* Receiving a diagnosis of OSA after polysomnography,
* Having an Apnea-Hypopnea Index ≥5 for OSA,
* Volunteering to participate in the study.
Exclusion Criteria:
* Having severe orthopedic, neurological, or cardiac diseases,
* Having a diagnosed lung disease,
* Having a previous or current history of psychiatric or neurological disorders,
* Not voluntarily participating in the study.
+Locations (1)
| Facility | City | Country | Status |
|---|
| Karabük Training and Research Hospital | Karabük | Turkey (Türkiye) | Recruiting |
+Investigators
- Musa Güneş, PhD, Principal investigator, Karabuk University